Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-25-007073

Options or other derivatives

  • Chief Development Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jalota Deepika Chief Development Officer 2025-03-03 Grant or award · Employee Stock Option (right to buy) +300,000 300,000 D
Loading xslF345X05/form4-03052025_110323.xml…